Abstract

Antiviral effectors such as Natural Killer (NK) cells have impaired functions in chronic hepatitis B (CHB) patients. The molecular mechanism responsible for this dysfunction remains poorly characterized. We show that decreased cytokine production capacity of peripheral NK cells from CHB patients was associated with reduced expression of NKp30 and CD16, and defective mTOR pathway activity. Transcriptome analysis of patients NK cells revealed an enrichment for transcripts expressed in exhausted T cells suggesting that NK cell dysfunction and T cell exhaustion employ common mechanisms. In particular, the transcription factor TOX and several of its targets were over-expressed in NK cells of CHB patients. This signature was predicted to be dependent on the calcium-associated transcription factor NFAT. Stimulation of the calcium-dependent pathway recapitulated features of NK cells from CHB patients. Thus, deregulated calcium signalling could be a central event in both T cell exhaustion and NK cell dysfunction occurring during chronic infections.

Data availability

Sequencing data have been deposited in GEO under accession codes GSE153946.

The following data sets were generated

Article and author information

Author details

  1. Marie Marotel

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Marine Villard

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Annabelle Drouillard

    International Center for Infectiology Research (CIRI), Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Issam Tout

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Laurie Besson

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Omran Allatif

    International Center for Infectiology Research (CIRI), Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Marine Pujol

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Yamila Rocca

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Michelle Ainouze

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Guillaume Roblot

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  11. Sébastien Viel

    International Center for Infectiology Research (CIRI), Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5085-443X
  12. Melissa Gomez

    Hepathology, CHU Limoges, Limoges, France
    Competing interests
    The authors declare that no competing interests exist.
  13. Veronique Loustaud

    Hepathology, CHU Limoges, Limoges, France
    Competing interests
    The authors declare that no competing interests exist.
  14. Sophie Alain

    Hepathology, CHU Limoges, Limoges, France
    Competing interests
    The authors declare that no competing interests exist.
  15. David Durantel

    Cancerology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  16. Thierry Walzer

    International Center for Infectiology Research (CIRI), Lyon, France
    For correspondence
    thierry.walzer@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0857-8179
  17. Uzma Hasan

    Immunology, Inserm, Lyon, France
    For correspondence
    uzma.hasan@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
  18. Antoine Marçais

    International Center for Infectiology Research (CIRI), Lyon, France
    For correspondence
    antoine.marcais@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3591-6268

Funding

Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ECTZ22398)

  • Uzma Hasan

Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ECTZ11169)

  • Uzma Hasan

Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ECTZ19856)

  • Uzma Hasan

Agence Nationale de la Recherche (BaNK)

  • Antoine Marçais

Agence Nationale de la Recherche (SPHINKS)

  • Thierry Walzer

Association de Recherche sur le Cancer (Equipe labellisée)

  • Thierry Walzer

H2020 European Research Council (ERC-Stg 281025)

  • Thierry Walzer

La Ligue Nationale contre le Cancer (Graduate student fellowship)

  • Marie Marotel

La Ligue du Rhone (LNCC)

  • Uzma Hasan

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: All participants provided written informed consent in accordance with the procedure approved by the local ethics committee (Comité de Protection des Personnes, Centre Hospitalier Universitaire de Limoges, Limoges, France) and the Interventional research protocol involving human samples (Code promotor LiNKeB project: 87RI18-0021).

Copyright

© 2021, Marotel et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,522
    views
  • 363
    downloads
  • 30
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Marie Marotel
  2. Marine Villard
  3. Annabelle Drouillard
  4. Issam Tout
  5. Laurie Besson
  6. Omran Allatif
  7. Marine Pujol
  8. Yamila Rocca
  9. Michelle Ainouze
  10. Guillaume Roblot
  11. Sébastien Viel
  12. Melissa Gomez
  13. Veronique Loustaud
  14. Sophie Alain
  15. David Durantel
  16. Thierry Walzer
  17. Uzma Hasan
  18. Antoine Marçais
(2021)
Peripheral Natural Killer cells in chronic hepatitis B patients display multiple molecular features of T cell exhaustion
eLife 10:e60095.
https://doi.org/10.7554/eLife.60095

Share this article

https://doi.org/10.7554/eLife.60095

Further reading

    1. Cancer Biology
    2. Immunology and Inflammation
    Simei Go, Constantinos Demetriou ... Eric O Neill
    Research Article

    The immunosuppressive microenvironment in pancreatic ductal adenocarcinoma (PDAC) prevents tumor control and strategies to restore anti-cancer immunity (i.e. by increasing CD8 T-cell activity) have had limited success. Here, we demonstrate how inducing localized physical damage using ionizing radiation (IR) unmasks the benefit of immunotherapy by increasing tissue-resident natural killer (trNK) cells that support CD8 T activity. Our data confirms that targeting mouse orthotopic PDAC tumors with IR together with CCR5 inhibition and PD1 blockade reduces E-cadherin positive tumor cells by recruiting a hypoactive NKG2D-ve NK population, phenotypically reminiscent of trNK cells, that supports CD8 T-cell involvement. We show an equivalent population in human single-cell RNA sequencing (scRNA-seq) PDAC cohorts that represents immunomodulatory trNK cells that could similarly support CD8 T-cell levels in a cDC1-dependent manner. Importantly, a trNK signature associates with survival in PDAC and other solid malignancies revealing a potential beneficial role for trNK in improving adaptive anti-tumor responses and supporting CCR5 inhibitor (CCR5i)/αPD1 and IR-induced damage as a novel therapeutic approach.

    1. Immunology and Inflammation
    Jasmine Rowell, Ching-In Lau ... Tessa Crompton
    Research Article

    Here, we sequenced rearranged TCRβ and TCRα chain sequences in CD4+CD8+ double positive (DP), CD4+CD8- single positive (SP4) and CD4-CD8+ (SP8) thymocyte populations from the foetus and young adult mouse. We found that life-stage had a greater impact on TCRβ and TCRα gene segment usage than cell-type. Foetal repertoires showed bias towards 3’TRAV and 5’TRAJ rearrangements in all populations, whereas adult repertoires used more 5’TRAV gene segments, suggesting that progressive TCRα rearrangements occur less frequently in foetal DP cells. When we synchronised young adult DP thymocyte differentiation by hydrocortisone treatment the new recovering DP thymocyte population showed more foetal-like 3’TRAV and 5’TRAJ gene segment usage. In foetus we identified less influence of MHC-restriction on α-chain and β-chain combinatorial VxJ usage and CDR1xCDR2 (V region) usage in SP compared to adult, indicating weaker impact of MHC-restriction on the foetal TCR repertoire. The foetal TCRβ repertoire was less diverse, less evenly distributed, with fewer non-template insertions, and all foetal populations contained more clonotypic expansions than adult. The differences between the foetal and adult thymus TCR repertoires are consistent with the foetal thymus producing αβT-cells with properties and functions that are distinct from adult T-cells: their repertoire is less governed by MHC-restriction, with preference for particular gene segment usage, less diverse with more clonotypic expansions, and more closely encoded by genomic sequence.